These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20569983)

  • 41. Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog.
    Takami A; Nakao S; Ontachi Y; Yamauchi H; Matsuda T
    Int J Hematol; 1999 Jan; 69(1):24-6. PubMed ID: 10641439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation.
    Nishimaki J; Miyazawa K; Yaguchi M; Katagiri T; Kawanishi Y; Toyama K; Ohyashiki K; Hashimoto S; Nakaya K; Takiguchi T
    Leukemia; 1999 Sep; 13(9):1399-405. PubMed ID: 10482991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.
    Gonzalez-Lugo JD; Kambhampati S; Yacoub A; Donnellan WB; Berdeja J; Bhagat P; Fehn K; Remy C; Jasra S; Kazemi M; Pradhan K; Kim M; Mantzaris I; Sica RA; Shah N; Goldfinger M; Kornblum N; Gritsman K; Braunschweig I; Steidl U; Will B; Shastri A; Verma A
    Clin Cancer Res; 2023 Jan; 29(1):60-66. PubMed ID: 36255372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menatetrenone plus alfacalcidol treatment for bone problems in eight children with skeletal unloading.
    Sugiyama T; Saito Y; Kaichi I; Sugi M; Tanaka H; Kawai S
    J Bone Miner Metab; 2000; 18(1):41-4. PubMed ID: 10633277
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of myelodysplastic syndrome with alfacalcidol].
    Tagawa M; Ito H; Kuriyama K; Tomonaga M; Ichimaru M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3160-2. PubMed ID: 3674901
    [No Abstract]   [Full Text] [Related]  

  • 46. Therapeutic trial of hematological disorders with intermittent administration of high-dose 1-alpha-hydroxyvitamin D3.
    Imai Y; Tsutsumi M; Tsunenari T; Nishikawa M; Matsui T; Natazuka T; Fujita T
    Contrib Nephrol; 1991; 91():95-101. PubMed ID: 1800016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the antitumor effects of vitamin K
    Shi J; Zhou S; Kang L; Ling H; Chen J; Duan L; Song Y; Deng Y
    Drug Deliv Transl Res; 2018 Feb; 8(1):1-11. PubMed ID: 28849577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes.
    Motomura S; Kanamori H; Maruta A; Kodama F; Ohkubo T
    Am J Hematol; 1991 Sep; 38(1):67-8. PubMed ID: 1897516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin K2 in multiple sclerosis patients.
    Lasemi R; Kundi M; Moghadam NB; Moshammer H; Hainfellner JA
    Wien Klin Wochenschr; 2018 May; 130(9-10):307-313. PubMed ID: 29500722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes.
    Kelsey SM; Newland AC; Cunningham J; Makin HL; Coldwell RD; Mills MJ; Grant IR
    Lancet; 1992 Aug; 340(8814):316-7. PubMed ID: 1353239
    [No Abstract]   [Full Text] [Related]  

  • 51. Vitamin K2 Enhances Fat Degradation to Improve the Survival of
    Qu Z; Zhang L; Huang W; Zheng S
    Front Nutr; 2022; 9():858481. PubMed ID: 35495953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Research progress on the anticancer effects of vitamin K2.
    Xv F; Chen J; Duan L; Li S
    Oncol Lett; 2018 Jun; 15(6):8926-8934. PubMed ID: 29805627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.
    Greenberg PL; Tuechler H; Schanz J; Sanz G; Garcia-Manero G; Solé F; Bennett JM; Bowen D; Fenaux P; Dreyfus F; Kantarjian H; Kuendgen A; Levis A; Malcovati L; Cazzola M; Cermak J; Fonatsch C; Le Beau MM; Slovak ML; Krieger O; Luebbert M; Maciejewski J; Magalhaes SM; Miyazaki Y; Pfeilstöcker M; Sekeres M; Sperr WR; Stauder R; Tauro S; Valent P; Vallespi T; van de Loosdrecht AA; Germing U; Haase D
    Blood; 2016 Oct; 128(16):2096-2097. PubMed ID: 27535995
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trial.
    Ishizuka M; Kubota K; Shimoda M; Kita J; Kato M; Park KH; Shiraki T
    Anticancer Res; 2012 Dec; 32(12):5415-20. PubMed ID: 23225445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
    Tauchi T; Moriya S; Okabe S; Kazama H; Miyazawa K; Takano N
    PLoS One; 2024; 19(7):e0307662. PubMed ID: 39052583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin K2 enhances the tumor suppressive effects of 1,25(OH)
    Narvaez CJ; Bak MJ; Salman N; Welsh J
    J Steroid Biochem Mol Biol; 2023 Jul; 231():106307. PubMed ID: 37030416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrative Hematology: State of the Art.
    Andreazzoli F; Bonucci M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Vitamin D on Graft-versus-Host Disease.
    Rodríguez-Gil A; Carrillo-Cruz E; Marrero-Cepeda C; Rodríguez G; Pérez-Simón JA
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cat with myelodysplastic syndrome by administration of the methylation inhibitor Azacytidine.
    Hisasue M; Tanaka M; Neo S
    J Vet Med Sci; 2022 Jan; 84(1):142-148. PubMed ID: 34866071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.